28783-18-8 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
3-Bromothieno[3,2-c]pyridine is utilized as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the creation of novel compounds with potential therapeutic and pesticidal properties, contributing to the development of new drugs and crop protection agents.
Used in Organic Electronic Devices:
3-Bromothieno[3,2-c]pyridine is being investigated for its potential use in organic electronic devices. Its electronic properties and structural features make it a promising candidate for applications such as organic light-emitting diodes (OLEDs), organic solar cells, and organic field-effect transistors (OFETs), where it can enhance device performance and stability.
Used as a Pharmaceutical Intermediate:
3-Bromothieno[3,2-c]pyridine also serves as a valuable pharmaceutical intermediate. Its reactivity and structural characteristics facilitate the synthesis of complex organic molecules, enabling the production of advanced pharmaceutical compounds with improved efficacy and selectivity.
Used in Material Science:
In the field of material science, 3-Bromothieno[3,2-c]pyridine is explored for its potential applications in the development of new materials with unique properties. Its incorporation into polymers, for instance, can lead to materials with enhanced thermal stability, electrical conductivity, or other desirable characteristics, broadening its utility in various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 28783-18-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,7,8 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 28783-18:
(7*2)+(6*8)+(5*7)+(4*8)+(3*3)+(2*1)+(1*8)=148
148 % 10 = 8
So 28783-18-8 is a valid CAS Registry Number.
28783-18-8Relevant academic research and scientific papers
IMIDAZOPYRIDAZINE COMPOUNDS
-
Page/Page column 92, (2008/06/13)
The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
